It Seems Like We Need to Look Into This Regarding the Dems' Candidate...
Speaker Johnson Had a Legislative Hat Trick Today While Thune Wants to Sell...
Police Chief Secretly Installs AI Surveillance Cameras, Then Justifies It After Getting Bu...
Who Are the Bullies Again?
Abdul El-Sayed Is Losing Black Voters, So the Damage Control Has Begun
WisDems Are Begging for an Early Voting Ballot Do-Over
Press Struggles With Immigrant Voting It Denies Happening; 'The View' Has Its Dress...
Minnesota Man Sentenced to 30 Months for $1.18M Tax Refund Scheme
70th Defendant Pleads Guilty in $250 Million Feeding Our Future Fraud
Maryland Audit: $2 Million Lottery Winner Kept Collecting Food Stamps
Day 12: U.S. Pounds Iran to Protect Ships in Strait of Hormuz
Rashida Tlaib Goes to Bat for Mamdani, Says She'll Help Arrest Netanyahu
New Jersey Man Sentenced to 48 Months in $4 Million Medicaid Fraud Scheme
Congressional Stock Trading Is About to Get Much Harder
Protecting, Saving and Spending: The Latest on Congressional Noise
Tipsheet

The CDC Director Just Gave Us an Updated Vaccine Timeline

The CDC Director Just Gave Us an Updated Vaccine Timeline
AP Photo/Alex Brandon

We've brought you a lot of exciting vaccine news these past few weeks. And there's more of it on Tuesday. Center for Disease Control Director Robert Redfield said Americans should expect a vaccine to be rolled out very, very soon. He predicted the second week of December.

Advertisement

The next question then is, who will be receiving the first doses. He answered that too.

In an interview with Fox News anchor Dana Perino, Redfield shared that the first groups to get the vaccine will probably be "nursing home residents and then some combination of health care providers and individuals at high risk for a poor outcome."

"I do think we'll have about 40 million doses of vaccine before the end of the...year," Redfield continued. "That's enough to vaccinate 20 million people. But then it will continue through January and February and hopefully by March we'll start to see vaccine available for the general public."

Advertisement

Pfizer, who vaccine its been developing with BioNTech has produced a 95 percent efficacy rate, requested an emergency authorization from the FDA. A second vaccine candidate being produced by Moderna isn't too far behind, reporting a 94 percent effectiveness. And then a third, developed by AstraZeneca, is up to 90 percent effective.

The FDA has reportedly scheduled a meeting for Dec. 10 with its Vaccines and Related Biological Products Advisory Committee to discuss Pfizer's request.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement